The New England Journal of Medicine: commercial conflict of interest and revisiting the Vioxx scandal

2016 ◽  
Author(s):  
Mark Wilson
Keyword(s):  
England Journal ◽  
New England ◽  
Conflict Of Interest

scholarly journals Accuracy of Conflict-of-Interest Disclosures of Physician-Authors Publishing in High-Impact U.S. Medical Journals: A Comparison of the Journal of the American Medical Association and the New England Journal of Medicine

2021 ◽  
Author(s):  
James H Baraldi ◽  
Steven Picozzo ◽  
Jacob Arnold ◽  
Kathryn Volarich ◽  
Michael Gionfriddo ◽  
...  
Keyword(s):  
England Journal ◽  
American Medical Association ◽  
Medical Association ◽  
New England ◽  
American Medical ◽  
Conflict Of Interest ◽  
Cross Sectional ◽  
Medical Journals ◽  
Clinical Trial Research ◽  
Open Payments

Objective: To assess the accuracy of self-reported financial conflict-of-interest (COI) disclosures in the New England Journal of Medicine (NEJM) and Journal of the American Medical Association (JAMA) within the requisite disclosure period prior to article submission. Design: Cross-sectional investigation. Data Sources: Original clinical-trial research articles published in NEJM (n = 206) or JAMA (n = 188) from January 1 to December 31, 2017; self-reported COI disclosure forms submitted to NEJM or JAMA with the authors published articles; Open Payments website (from database inception; latest search: August 2019). Main outcome measures: Financial data reported to Open Payments from 2014 to 2016 (time period that included all subjects requisite disclosure windows) were compared to self-reported disclosure forms submitted to the journals. Payments were defined as those not associated with a research study or formal research funding. Payment types were categorized as disclosed, undisclosed, indeterminate, or unrelated. Results: Thirty-one articles from NEJM and 31 articles from JAMA met inclusion criteria. The physician-authors (n = 118) received a combined total of $7.48 million. Of the 106 authors (89.8%) who received payments, 86 (81.1%) received undisclosed payments. The top 23 most highly compensated received $6.32 million, of which $3.00 million (47.6%) was undisclosed. Disclosure rates were the equivalent between the top 23 and the entire sample. Conclusions: High payment amounts, as well as high proportions of undisclosed financial compensation, regardless of amount received, comprised potential COIs for two influential US medical journals. Further research is needed to explain why such high proportions of general payments were undisclosed and whether journals that rely on self-reported COI disclosure need to reconsider their policies.

Is Bioethics for Sale? The Dilemmas of Conflict of Interest

2003 ◽  
Vol 24 (2) ◽  
pp. 45-60
Author(s):  
Dorothy Nelkin
Keyword(s):  
England Journal ◽  
New England ◽  
Conflict Of Interest ◽  
Wall Street Journal ◽  
Yale University ◽  
Wall Street ◽  
The Wall Street Journal ◽  
Board Room

“Science, wrote a former Dean of Yale University, has moved from the classroom to the board room; from the New England Journal to the Wall Street Journal.”

Molekularbiologie

2018 ◽  
Vol 09 (05) ◽  
pp. 242-243
Author(s):  
Dr. Susanne Krome
Keyword(s):  
England Journal ◽  
Medical School ◽  
New England ◽  
Harvard Medical School

Zehntausende nichtproteinkodierende RNAs haben die Kenntnisse über die normale Physiologie sowie die Entstehung und Behandlung von Krankheiten auf den Kopf gestellt, schreibt Prof. Frank Slack, Harvard Medical School, Boston/USA, im New England Journal of Medicine über den überwiegenden Teil unseres Genoms. Diese RNA-Sub typen regulieren Wachstum, Entwicklung und Organfunktion. Ihre Gewebespezifität eröffnet neue, unerwartete Möglichkeiten in der Onkologie. Der größte Teil ihrer Funktionen ist allerdings noch nicht erforscht.

Sign in / Sign up

Export Citation Format

Share Document